These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 17334957)

  • 1. Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.
    Díez FI; Straube A; Zanchin G
    J Neurol; 2007 Feb; 254(2):242-9. PubMed ID: 17334957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Almotriptan versus rizatriptan in patients with migraine in Spain.
    Leira R; Dualde E; del Barrio H; Machuca M; López-Gil A;
    Headache; 2003; 43(7):734-41. PubMed ID: 12890128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
    Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
    Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
    Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M;
    Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
    Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K;
    Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L;
    Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    McCormack PL; Foster RH
    Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine treatment with rizatriptan and almotriptan: a crossover study.
    Ng-Mak DS; Hu XH; Bigal M
    Headache; 2009 May; 49(5):655-62. PubMed ID: 19456878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
    Krymchantowski AV; Barbosa JS
    Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and efficacy of almotriptan in the long-term treatment of migraine.
    Pascual J; Falk R; Docekal R; Prusinski A; Jelencsik J; Cabarrocas X; Segarra X; Luria X; Ferrer P
    Eur Neurol; 2001; 45(4):206-13. PubMed ID: 11385257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
    Williams P; Reeder CE
    Clin Ther; 2003 Nov; 25(11):2903-19. PubMed ID: 14693315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rizatriptan: an update of its use in the management of migraine.
    Wellington K; Plosker GL
    Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of almotriptan in triptan-experienced and triptan-naïve patients.
    Pascual J; Diener HC
    Curr Med Res Opin; 2007 Oct; 23(10):2433-40. PubMed ID: 17723158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.
    Savi L; Omboni S; Lisotto C; Zanchin G; Ferrari MD; Zava D; Pinessi L
    J Headache Pain; 2011 Apr; 12(2):219-26. PubMed ID: 20686810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
    Gershovich OE; Billups SJ; Delate T; Hoffman CK; Carroll N
    J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.